2026 Q2 Portfolio Activity
In 2026 Q2, Venrock Adviser, LLC maintained a portfolio of 37 distinct positions. The most significant new addition was ACHIEVE LIFE SCIENCE INC, now representing 0.54% of the total fund value. They heavily accumulated shares in X4 PHARMACEUTICALS INC, increasing the position by 485.2%. Conversely, Venrock Adviser, LLC completely exited their position in KALVISTA PHARMACEUTICALS INC.
Position History
hover any row below to update
Loading…
Total Positions
37
Quarter
2026 Q2
Top Holding
APGE (34.2%)
Top 10 Concentration
80.4%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-37 of 37
Venrock Adviser, LLC Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
APGE
APOGEE THERAPEU...
|
Healthcare | 34.18% | 26.68% |
#1
Prev: #1
|
7.0 |
—
|
no change | no change |
P
S
|
8,493,321 | $1,127,318,496 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ORKA
ORUKA THERAPEUT...
|
Healthcare | 11.97% | 7.60% |
#2
1
Prev: #3
|
6.5 |
—
|
no change | no change |
P
S
|
4,148,428 | $394,805,893 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ERAS
ERASCA INC
|
Healthcare | 9.94% | 9.89% |
#3
1
Prev: #2
|
7.0 |
—
|
1,509,000 | 9.2% |
P
S
|
17,891,812 | $327,777,996 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SYRE
SPYRE THERAPEUT...
|
Healthcare | 8.04% | 6.94% |
#4
Prev: #4
|
4.2 |
—
|
-700,000 | -19.0% |
P
S
|
2,985,448 | $265,048,073 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 3.49% | 3.70% |
#5
1
Prev: #6
|
2.9 |
—
|
no change | no change |
P
S
|
1,180,000 | $115,026,400 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
OCUL
OCULAR THERAPEU...
|
Healthcare | 3.08% | 3.27% |
#6
2
Prev: #8
|
2.2 |
—
|
no change | no change |
P
S
|
10,346,926 | $101,606,813 | 2023 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
GLTO
DAMORA THERAPEU...
|
Healthcare | 2.84% | 3.48% |
#7
Prev: #7
|
2.1 |
—
|
no change | no change |
P
S
|
3,603,595 | $93,729,506 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SVRA
SAVARA INC
|
Healthcare | 2.75% | 2.80% |
#8
3
Prev: #11
|
3.1 |
—
|
1,005,568 | 7.3% |
P
S
|
14,745,943 | $90,835,009 | 2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
JBIO
JADE BIOSCIENCE...
|
Healthcare | 2.17% | 1.69% |
#9
8
Prev: #17
|
1.9 |
—
|
no change | no change |
P
S
|
3,220,364 | $71,556,488 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 1.93% | 2.87% |
#10
1
Prev: #9
|
1.3 |
—
|
-357,834 | -17.9% |
P
S
|
1,642,166 | $63,551,824 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 1.81% | 2.83% |
#11
1
Prev: #10
|
1.2 |
—
|
-624,792 | -16.1% |
P
S
|
3,257,917 | $59,847,935 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VOR
VOR BIOPHARMA I...
|
Healthcare | 1.70% | 2.03% |
#12
2
Prev: #14
|
1.7 |
—
|
no change | no change |
P
S
|
3,041,719 | $55,998,047 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DYN
DYNE THERAPEUTI...
|
Healthcare | 1.46% | 1.47% |
#13
5
Prev: #18
|
1.6 |
—
|
no change | no change |
P
S
|
2,173,913 | $48,282,608 | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MAZE
MAZE THERAPEUTI...
|
Healthcare | 1.45% | 1.78% |
#14
1
Prev: #15
|
1.6 |
—
|
no change | no change |
P
S
|
1,602,034 | $47,804,695 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RLMD
RELMADA THERAPE...
|
Healthcare | 1.44% | 1.26% |
#15
6
Prev: #21
|
3.1 |
—
|
2,000,925 | 41.3% |
P
S
|
6,844,305 | $47,362,591 | 2020 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 1.42% | 2.04% |
#16
3
Prev: #13
|
1.6 |
—
|
no change | no change |
P
S
|
4,319,765 | $46,783,055 | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
CRESCENT BIOPHA...
|
|
Unknown | 1.16% | 1.46% |
#17
2
Prev: #19
|
1.5 |
—
|
no change | no change |
P
S
|
2,133,576 | $38,404,368 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
ZURA
ZURA BIO LTD
|
Healthcare | 1.15% | 1.43% |
#18
2
Prev: #20
|
1.5 |
—
|
no change | no change |
P
S
|
6,434,990 | $37,966,441 | 2024 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ANL
ADLAI NORTYE LT...
|
Healthcare | 1.12% | 0.83% |
#19
5
Prev: #24
|
1.4 |
—
|
no change | no change |
P
S
|
3,212,731 | $36,946,407 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 0.81% | 2.53% |
#20
8
Prev: #12
|
0.3 |
—
|
-1,200,000 | -69.5% |
P
S
|
526,331 | $26,711,298 | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CYBN
CYBIN INC
|
Unknown | 0.77% | 0.69% |
#21
6
Prev: #27
|
1.3 |
—
|
no change | no change |
P
S
|
3,851,654 | $25,459,433 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CGEM
CULLINAN THERAP...
|
Healthcare | 0.76% | 0.73% |
#22
4
Prev: #26
|
1.3 |
—
|
no change | no change |
P
S
|
1,379,965 | $25,129,163 | 2021 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IPSC
CENTURY THERAPE...
|
Healthcare | 0.65% | 0.73% |
#23
2
Prev: #25
|
1.3 |
—
|
no change | no change |
P
S
|
8,695,652 | $21,304,347 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ARTV
ARTIVA BIOTHERA...
|
Healthcare | 0.60% | 0.39% |
#24
8
Prev: #32
|
2.7 |
—
|
434,027 | 27.0% |
P
S
|
2,043,596 | $19,822,881 | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CTMX
CYTOMX THERAPEU...
|
Healthcare | 0.57% | 1.75% |
#25
9
Prev: #16
|
0.2 |
—
|
-5,000,000 | -50.1% |
P
S
|
4,982,124 | $18,682,965 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ACHV
ACHIEVE LIFE SC...
|
Healthcare | 0.54% | — |
#26
Prev: #—
|
3.7 |
—
|
2,751,032 | — |
NEW
|
2,751,032 | $17,964,239 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
PARABILIS MEDIC...
|
|
Unknown | 0.52% | — |
#27
Prev: #—
|
3.7 |
—
|
625,000 | — |
NEW
|
625,000 | $17,106,250 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
SRZN
SURROZEN INC
|
Healthcare | 0.50% | 0.69% |
#28
Prev: #28
|
1.2 |
—
|
no change | no change |
P
S
|
632,931 | $16,424,559 | 2025 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KRRO
KORRO BIO INC
|
Healthcare | 0.40% | 0.43% |
#29
1
Prev: #30
|
1.2 |
—
|
no change | no change |
P
S
|
1,009,500 | $13,305,210 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ANRO
ALTO NEUROSCIEN...
|
Healthcare | 0.40% | 0.42% |
#30
1
Prev: #31
|
1.2 |
—
|
no change | no change |
P
S
|
500,000 | $13,195,000 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
XFOR
X4 PHARMACEUTIC...
|
Healthcare | 0.27% | 0.05% |
#31
2
Prev: #33
|
3.1 |
—
|
1,603,728 | 485.2% |
P
S
|
1,934,253 | $9,032,962 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
RESEARCH ALLIAN...
|
|
Unknown | 0.10% | — |
#32
Prev: #—
|
3.5 |
—
|
300,000 | — |
NEW
|
300,000 | $3,210,000 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
INM
INMED PHARMACEU...
|
Healthcare | 0.00% | — |
#33
Prev: #—
|
3.5 |
—
|
32,685 | — |
NEW
|
32,685 | $50,662 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SEPN
SEPTERNA INC
|
Healthcare | 0.00% | 0.45% |
Sold All 😨
(Was: #29) |
0.0 |
—
|
-506,056 | -100.0% |
CLOSED
|
— | $— | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TENX
TENAX THERAPEUT...
|
Healthcare | 0.00% | 1.00% |
Sold All 😨
(Was: #23) |
0.0 |
—
|
-1,675,262 | -100.0% |
CLOSED
|
— | $— | 2024 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ENGN
ENGENE HOLDINGS...
|
Healthcare | 0.00% | 1.21% |
Sold All 😨
(Was: #22) |
0.0 |
—
|
-4,771,414 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KALV
KALVISTA PHARMA...
|
Healthcare | 0.00% | 4.86% |
Sold All 😨
(Was: #5) |
0.0 |
—
|
-6,474,485 | -100.0% |
CLOSED
|
— | $— | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-37 of 37 holdings